A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1538-7836.2003.00153.xPMID 12871399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The protein C pathway.

  2003cited by this paper
• Dysfunction of endothelial protein C activation in severe meningococcal sepsis.

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis.

  2001cited by this paper
• Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor.

  2001cited by this paper
• The Interaction of a Ca 2 +-dependent Monoclonal Antibody with the Protein C Activation Peptide Region

  2001cited by this paper
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis*

  2001cited by this paper
• Vitronectin Functions as a Cofactor for Rapid Inhibition of Activated Protein C by Plasminogen Activator Inhibitor-1

  2001cited by this paper
• Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway.

  2001cited by this paper
• The protein C pathway

  2000cited by this paper
• Three-dimensional Model of Coagulation Factor Va Bound to Activated Protein C

  2000cited by this paper
• Protein C levels as a prognostic indicator of outcome in sepsis and related diseases

  2000cited by this paper
• Modeling zymogen protein C.

  2000cited by this paper
• Metalloproteolytic Release of Endothelial Cell Protein C Receptor*

  2000cited by this paper
• AGE-SPECIFIC INCIDENCE AND OUTCOME OF SEPSIS IN THE US

  1999cited by this paper
• Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).

  1998cited by this paper
• Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin Interaction of Coagulation Defects and Cardiovascular Risk Factors : Increased

  1998cited by this paper
• A Common Thrombomodulin Amino Acid Dimorphism Is Associated with Myocardial Infarction

  1997cited by this paper
• A Novel Thrombomodulin Gene Mutation in a Patient Suffering from Sagittal Sinus Thrombosis

  1997cited by this paper
• Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.

  1997cited by this paper
• Thrombomodulin gene mutations associated with myocardial infarction.

  1997cited by this paper
• The 2.8 A crystal structure of Gla‐domainless activated protein C.

  1996cited by this paper
• Inherited Thrombophilia: Part 1

  1996cited by this paper
• Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.

  1996cited by this paper
• The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial Cells

  1996cited by this paper
• Quantification of Circulating Activated Protein C in Human Plasma by Immunoassays - Enzyme Levels are Proportional to Total Protein C Levels

  1996cited by this paper
• Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide.

  1994cited by this paper
• Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.

  1994cited by this paper
• Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor.

  1994cited by this paper
• Protein C activation.

  1993cited by this paper
• Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

  1993cited by this paper
• A Sensitive and Facile Assay for the Measurement of Activated Protein C Activity Levels in Vivo

  1993cited by this paper
• The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives.

  1992cited by this paper
• Direct detection of activated protein C in blood from human subjects.

  1992cited by this paper
• C4b-binding protein exacerbates the host response to Escherichia coli.

  1991cited by this paper
• The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibody.

  1988cited by this paper
• Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells

  1988cited by this paper
• The Interaction of Activated Protein C and Thrombin with the Plasminogen Activator Inhibitor Released from Human Endothelial Cells

  1987cited by this paper
• Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

  1987cited by this paper
• Purpura fulminans in meningococcemia: association with acquired deficiencies of proteins C and S.

  1987cited by this paper
• Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.

  1986cited by this paper
• Protein C Activation

  1984cited by this paper

• Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study

  2023cites this paper
• New plasma protein C and protein S concentrate: A synergy for therapeutic purposes

  2023cites this paper
• Increased activated protein C to protein C ratio in sepsis and cirrhosis.

  2021cites this paper
• Activated Protein C Strengthens Cardiac Tolerance to Ischemic Insults in Aging

  2021cites this paper
• Activated protein C assays: a review.

  2019cites this paper
• Coagulation Abnormalities in Sepsis

  2019cites this paper
• Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State.

  2017cites this paper
• Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype

  2017cites this paper
• The impact of the endothelial protein C receptor on thrombin generation and clot lysis.

  2017cites this paper
• Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia‐reperfusion injury

  2017cites this paper
• Low‐grade endotoxemia and clotting activation in the early phase of pneumonia

  2016cites this paper
• High dose antithrombin supplementation in early preeclampsia: A randomized, double blind, placebo-controlled study.

  2016cites this paper
• A simplified assay for the quantification of circulating activated protein C.

  2016cites this paper
• Circulating activated protein C in thrombophilia carriers

  2016cites this paper
• Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock

  2015cites this paper
• Coagulation and fibrinolysis in tuberculosis, melioidosis and beyond

  2014cites this paper
• Anti-Inflammatory Functions of Protein C Require RAGE and ICAM-1 in a Stimulus-Dependent Manner

  2014cites this paper
• RAGE Controls Activation and Anti-Inflammatory Signalling of Protein C

  2014cites this paper
• Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses

  2014cites this paper
• UvA-DARE ( Digital Academic Repository ) Allergic asthma : Environmental factors challenging the immune system

  2013cites this paper
• Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma‐shock (COT/ACOTS)

  2013cites this paper
• Fluorogenic assays for activated protein C using aptamer modified magnetic beads

  2013influential citation
• Effect of cardiopulmonary bypass on thrombin generation and protein C pathway.

  2013cites this paper
• Platelet Endothelial Cell Adhesion Molecule Targeted Oxidant-Resistant Mutant Thrombomodulin Fusion Protein with Enhanced Potency In Vitro and In Vivo

  2013cites this paper
• Overexpression of Activated Protein C is Detrimental During Severe Experimental Gram-Negative Sepsis (Melioidosis)*

  2013cites this paper
• Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock.

  2013cites this paper
• Quantitative analysis of thrombomodulin-mediated conversion of protein C to APC: translation from in vitro to in vivo.

  2012cites this paper
• Proteolytische Aktivität von APC bei der Inaktivierung verschiedener Faktor VIII-Präparate und bei der Faktor VIIIa-Inaktivierung in Gegenwart eines APC-DNA-Aptamers

  2012cites this paper
• Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide‐based enzyme capture assay

  2012cites this paper
• The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis

  2011cites this paper
• Impact of Chemotherapy on Thrombin Generation and on the Protein C Pathway in Breast Cancer Patients

  2011cites this paper
• Modulation of Hemostatic Pathways by Breast Cancer Chemotherapy Agents

  2011cites this paper
• Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.

  2011cites this paper
• The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal‐based and cell‐based models

  2011cites this paper
• Protein C concentrate controls leukocyte recruitment during inflammation and improves survival during endotoxemia after efficient in vivo activation.

  2011cites this paper
• Profiling of active thrombin in human blood by supramolecular complexes.

  2011cites this paper
• PROTEIN C AND SOLUBLE THROMBOMODULIN IN RELATION TO TUMOR NECROSIS FACTOR-α IN CRITICALLY ILL SEPTIC PATIENTS AND THEIR CORRELATION WITH SOFA SCORE

  2010influential citation
• respiratory pathogens and lipopolysaccharide Activated Protein C have an unaltered pulmonary immune response to Thrombomodulin mutant mice with a strongly reduced capacity to generate

  2010cites this paper
• UvA-DARE ( Digital Academic Repository ) Immunotolerance during bacterial pneumonia and sepsis

  2010cites this paper
• Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide*

  2009cites this paper
• Hematological diseases and stroke.

  2009cites this paper
• Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery

  2009cites this paper
• of fibrinolysis in the human lung upon bronchial instillation of lipoteichoic acid and lipopolysaccharide

  2009cites this paper
• Early activation of coagulation after allergen challenge in patients with allergic asthma

  2009cites this paper
• Thrombin physiology and pathophysiology.

  2009cites this paper
• Role of the protein C pathway in the extraintestinal thrombosis associated with murine colitis.

  2008cites this paper
• Crosstalk between inflammation and thrombosis.

  2008cites this paper
• Reprint of Crosstalk between inflammation and thrombosis

  2008cites this paper
• Lung protective mechanical ventilation

  2008cites this paper
• Activated protein C in sepsis: a critical review

  2008cites this paper
• Salmeterol enhances pulmonary fibrinolysis in healthy volunteers

  2007cites this paper
• Development of Methods for Measuring Protein C Inhibitor and Antithrombin: Use of Monoclonal Antibodies against the Reactive Center Loop-Inserted Forms of the Serpins

  2007cites this paper
• Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats

  2007cites this paper
• The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977–2007)

  2007cites this paper
• Development of Methods for Measuring Protein C Inhibitor and Antithrombin: Use of Monoclonal Antibodies against the Reactive Center Loop-Inserted Forms of the Serpins Kjellberg, Margareta

  2007cites this paper
• Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway.

  2007cites this paper
• Mechanical Ventilation with Lower Tidal Volumes and Positive End-expiratory Pressure Prevents Alveolar Coagulation in Patients without Lung Injury

  2006cites this paper
• A novel ELISA for mouse activated protein C in plasma.

  2006cites this paper
• The complex between activated protein C and protein C inhibitor: A clinically useful indicator of aortic aneurysms?

  2006cites this paper
• Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells*

  2006cites this paper
• Regulated readthrough: a new method for the alternative tagging and targeting of recombinant proteins.

  2006cites this paper
• Back to the future: testing in disseminated intravascular coagulation

  2005cites this paper
• Survey of the year 2003 commercial optical biosensor literature

  2005cites this paper
• Coagulation inhibitors in inflammation.

  2005cites this paper
• Protein C in pneumonia

  2005cites this paper
• Protein C in pneumonia.

  2005cites this paper
• Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans.

  2005cites this paper
• The interactions between inflammation and coagulation

  2005cites this paper
• reaction? strain type and TB paradoxical tuberculosis Mycobacterium Is there a relationship between

  2005cites this paper
• Activated protein C levels in patients with severe sepsis: rebuttal

  2004cites this paper
• Potential role of d‐dimer to rule in pulmonary embolism: a rebuttal

  2004cites this paper
• Effect of bezafibrate on plasma homocysteine concentration in men with lower extremity arterial disease

  2004cites this paper
• A new heterozygous mutation in gamma fibrinogen gene leading to 326 Cys→Ser substitution in fibrinogen Córdoba is associated with defective polymerization and familial hypodysfibrinogenemia

  2004cites this paper
• Vitamin K antagonists and cancer: rebuttal

  2004cites this paper
• Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide.

  2004cites this paper
• Rebuttal to: Clinical manifestations of the prothrombin G20210A mutation in children

  2004cites this paper
• The prevalence of factor V G1691A but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T is remarkably low in French Basques

  2004cites this paper
• The impact of the inflammatory response on coagulation.

  2004cites this paper
• Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra®) anti‐Xa activity

  2004cites this paper
• Production and purification of a chimeric monoclonal antibody against botulinum neurotoxin serotype A.

  2004cites this paper
• Protease-activated receptor signaling in the regulation of inflammation

  2004cites this paper
• Endogenous protein C activation in patients with severe sepsis

  2004cites this paper
• Methods that increase FVIII recovery in cryoprecipitate

  2004cites this paper
• Serum levels of interleukin‐10 are inversely related to future events in patients with acute myocardial infarction

  2004cites this paper
• [Disseminated intravascular coagulation].

  2004cites this paper
• Identification of an epitope on glycoprotein IIb‐IIIa that is recognized by HLA‐DRB1*0405‐restricted CD4+‘superior’ T cells from a patient with immune thrombocytopenic purpura

  2004cites this paper
• Interactions between the innate immune and blood coagulation systems

  2004cites this paper
• Measuring the binding strength of single ligand–receptor pairs on cells: rebuttal

  2004cites this paper
• Geography too determines the causes of inherited thrombophilia

  2004cites this paper
• High‐titer inhibitor development in hemophilia A: lack of product specificity

  2004cites this paper
• Crosstalk between inflammation and thrombosis.

  2004cites this paper
• Risk of venous thromboembolism during pregnancy in homozygous carriers of the factor V Leiden mutation: are there any predictive factors?

  2004cites this paper
• Activated protein C in sepsis

  2004cites this paper
• Potential role of d‐dimer to rule in pulmonary embolism: reply to a rebuttal

  2004cites this paper
• Vitamin K antagonists and cancer: reply to rebuttal

  2004cites this paper
• Measuring the binding strength of single ligand–receptor pairs on cells: reply to a rebuttal

  2004cites this paper
• The effect of a pneumatic tube transport system on PFA‐100™ closure time and whole blood platelet aggregation

  2004cites this paper
• Reply to rebuttal of: Clinical manifestations of the prothrombin G20210A mutation in children

  2004cites this paper
• Interaction between inflammation, coagulation and fibrinolysis during infection

  2004cites this paper
• Coagulation and Innate Immunity

  2004cites this paper